Xilio Development Inc share price logo

Xilio Development Inc

NASDAQ: XLO

Small Cap

$8.21

-0.14

(-1.73%)

Live

as on

Xilio Development Inc Stock Performance

as on May 19, 2026 at 3:32 am IST

  • Day's Low

    Day's High

    $8.19
    $8.59
    downward going graph

    0.24%

    Downside

    4.63%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $6.47
    $16.10
    downward going graph

    21.25%

    Downside

    96.10%

    Upside

    downward going graph

Xilio Development Inc share price movements today

Previous Close
$8.36
Open
$8.35
Volume
482.6K
Day's Low - High
$8.19 - $8.59
52 Week Low - High
$6.47 - $16.10

Xilio Development Inc Historical Returns

1 Month Return
-2.45 %
3 Month Return
+ 4.62 %
1 Year Return
-30.52 %
3 Year Return
-80.98 %
5 Year Return
0 %

Xilio Development Inc Stock Fundamentals & Key Indicators

Check Xilio Development Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$52.6M

EPS (TTM)

-2.39

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

EBITDA

-40.9M

Revenue (TTM)

53.5M

Profit Margin

-58.52%

Return On Equity TTM

-75.20%

Xilio Development Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Xilio Development Inc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
BUY$52.6MNANA-58.52%
BUY$31.8B341.26%NA0.00%
BUY$39.2B112.34%73.5512.55%
BUY$115.0B103.57%26.8935.51%
BUY$74.7B35.26%17.3929.65%

Stock Returns calculator for Xilio Development Inc Stock including INR - Dollar returns

The Xilio Development Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

Xilio Development Inc investment value today

Current value as on today

₹76,994

Returns

-₹23,006

(-23.01%)

Returns from Xilio Development Inc Stock

-₹31,754 (-31.75%)

Dollar Impact

₹8,748 (+8.75%)

Analyst Recommendation on Xilio Development Inc Stock

Based on 7 analysts

BUY

85.71%

Buy

14.29%

Hold

0.00%

Sell

Based on 7 analysts, 85.71% of analysts recommend a 'BUY' rating for Xilio Development Inc. Average target price of $20

Xilio Development Inc Share Price Target

Get share price movements and forecasts by analysts on Xilio Development Inc.

What analysts predicted

58.95%UPSIDE

Target Price

$20

Current Price

$8.21

Analyzed by

7 Analysts

Target

$20.00

Xilio Development Inc target price $20, a slight upside of 58.95% compared to current price of $8.21. According to 7 analysts rating.

Indian Investors' Interest in Xilio Development Inc Stock

Search interest for Xilio Development Inc Stock has decreased by -41% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-41% versus previous 30 day period

Xilio Development Inc Quarterly Profit & Loss

All numbers in Millions USD

Sep 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Total Revenue
-
2
2
2
1
2
8
19
13
12
Gross Profit
0
0
2
2
1
2
-7
19
13
12
Operating Income
-17
-17
-14
-14
-13
-13
-14
-1
-11
-14
EBITDA
-16
-16
-14
-14
-13
-13
-13
-1
-11
-13
Interest Expense
0
0
-
-
-
-
-
-
-
-
Depreciation
0
0
0
0
0
0
0
0
0
-
Income Before Tax
-16
-17
-13
-14
-13
-13
-15
-16
10
-9
Income Tax Expense
-1
1
-
-
-
-
-
-
-
-
Net Income
-16
-17
-13
-14
-13
-13
-15
-16
10
-9
Net Profit Margin
0.00%
-592.80%
-590.79%
-619.53%
-759.45%
-452.73%
-195.99%
-85.42%
75.70%
-75.34%

Xilio Development Inc Annual Profit & Loss

All numbers in Millions USD

Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
-
-
-
-
-
6
43
Gross Profit
0
-1
-1
-1
-1
6
42
Operating Income
-19
-54
-75
-89
-79
-60
-41
EBITDA
-17
-53
-73
-87
-77
-58
-40
Interest Expense
-
0
0
0
0
0
-
Depreciation
0
1
1
1
1
1
1
Income Before Tax
-17
-55
-75
-88
-76
-58
-35
Income Tax Expense
0
0
-1
0
0
-
-
Net Income
-17
-55
-74
-87
-76
-58
-35
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
-918.05%
-80.05%

Xilio Development Inc Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Net Income
-17
-13
-14
-13
-13
-15
-16
10
-9
Operating Cash Flow
-10
19
-13
-14
28
-14
-17
-1
-22
Investing Cash Flow
-
0
0
0
0
0
-
0
0
Financing Cash Flow
0
20
0
8
4
47
0
35
35
Change in Cash
-9
39
-13
-5
33
32
-17
33
12

Xilio Development Inc Annual Cash Flow

All numbers in Millions USD

Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-55
-75
-88
-76
-58
-35
Operating Cash Flow
-36
-80
-75
-68
-18
-4
Investing Cash Flow
-2
-1
-1
0
0
0
Financing Cash Flow
10
260
0
-6
29
87
Change in Cash
-28
178
-77
-75
10
82

Global Institutional Holdings in Xilio Development Inc

Funds
Holdings
XTX Topco Ltd
0.14%
Bain Capital Life Sciences Investors, LLC
8.8%
Two Sigma Investments LLC
0.12%
Ghisallo Capital Management LLC
1.33%
Takeda Pharmaceutical Co Ltd
1.82%

Insights on Xilio Development Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, XLO stock has moved up by 8.2%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Revolution Medicines, Inc. Common Stock has given 268.4% return, outperforming this stock by 298.9%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Revolution Medicines, Inc. Common Stock has given 473.9% return, outperforming this stock by 554.9%

About Xilio Development Inc

Xilio Therapeutics, Inc., a clinical-stage biotechnology company, engages in the discovery and development of masked immuno-oncology therapies. The company's pipeline includes XTX501, a bispecific PD-1 / masked IL-2, for patients with metastatic non-small cell lung cancer; Efarindodekin alfa, an investigational, masked IL-12, that is in Phase 2 clinical trial for patients with advanced solid tumors; and Vilastobart, an investigational tumor-activated, Fc-enhanced, high affinity binding anti-CTLA-4 monoclonal antibody. The company was founded in 2016 and is headquartered in Waltham, Massachusetts.
OrganisationXilio Development Inc
Headquarters828 Winter Street, Waltham, MA, United States, 02451
IndustryBiotechnology
CEODr. Rene Russo BCPS, Pharm.D.
E-voting on sharesClick here to vote

Key Management of Xilio Development Inc

Name

Title

Mr. Nathan McBride

Chief Information Officer

Ms. Caroline Hensley

Chief Legal Officer

Dr. Scott Coleman Ph.D.

Chief Development Officer

Ms. Ruth du Moulin

Senior Vice President of Medical Affairs

Dr. Katarina Luptakova M.D.

Chief Medical Officer

Mr. Christopher Frankenfield

CFO & COO

Mr. Kevin M. Brennan

Senior Vice President of Finance & Accounting

Dr. Uli Bialucha Ph.D.

Chief Scientific Officer

Dr. Rene Russo BCPS, Pharm.D.

President, CEO & Director

FAQs

What is Xilio Development Inc share price today?

Xilio Development Inc share price today is $8.21 as on . Xilio Development Inc share today touched a day high of $8.59 and a low of $8.19.

What is the 52 week high and 52 week low for Xilio Development Inc share?

Xilio Development Inc share touched a 52 week high of $16.1 on and a 52 week low of $6.47 on . Xilio Development Inc stock price today i.e. is trending at $8.21,which is 49.01% down from its 52 week high and 26.99% up from its 52 week low.

What is Xilio Development Inc's market capitalisation today?

Xilio Development Inc market capitalisation is $0.00T as on .

How to invest in Xilio Development Inc Stock (XLO) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Xilio Development Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Xilio Development Inc Shares that will get you 0.1827 shares as per Xilio Development Inc share price of $8.21 per share as on May 18, 2026 at 10:02 pm IST.

What is the minimum amount required to buy Xilio Development Inc Stock (XLO) from India?

Indian investors can start investing in Xilio Development Inc (XLO) shares with as little as ₹96.335 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹963.35 in Xilio Development Inc stock (as per the Rupee-Dollar exchange rate as on ). Based on Xilio Development Inc share’s latest price of $8.21 as on May 18, 2026 at 10:02 pm IST, you will get 1.2180 shares of Xilio Development Inc. Learn more about fractional shares .